Total Payments
$339,810
2024 Payments
$25,033
Companies
14
Transactions
120
Medicare Patients
87
Medicare Billing
$9,497
Payment Breakdown by Category
Consulting$162,581 (47.8%)
Research$78,409 (23.1%)
Travel$70,950 (20.9%)
Other$24,719 (7.3%)
Food & Beverage$3,070 (0.9%)
Education$80.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $162,581 | 43 | 47.8% |
| Unspecified | $78,409 | 8 | 23.1% |
| Travel and Lodging | $70,950 | 33 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,719 | 6 | 7.3% |
| Food and Beverage | $3,070 | 29 | 0.9% |
| Education | $80.81 | 1 | 0.0% |
Payments by Type
General
$261,400
112 transactions
Research
$78,409
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $130,506 | 50 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $86,162 | 15 | $0 (2022) |
| GENZYME CORPORATION | $32,620 | 17 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $30,045 | 11 | $0 (2023) |
| SOBI, INC | $28,398 | 8 | $0 (2024) |
| Dova Pharmaceuticals | $15,127 | 7 | $0 (2021) |
| Bio Products Laboratory USA, Inc. | $5,500 | 1 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $3,300 | 1 | $0 (2024) |
| Shionogi Inc | $3,133 | 5 | $0 (2018) |
| Janssen Research & Development, LLC | $1,500 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,033 | 10 | SOBI, INC ($17,644) |
| 2023 | $32,031 | 18 | GENZYME CORPORATION ($10,477) |
| 2022 | $47,869 | 10 | Rigel Pharmaceuticals, Inc. ($19,966) |
| 2021 | $72,039 | 10 | Rigel Pharmaceuticals, Inc. ($58,443) |
| 2020 | $10,613 | 6 | Novartis Pharmaceuticals Corporation ($4,500) |
| 2019 | $28,761 | 13 | Amgen Inc. ($20,557) |
| 2018 | $86,062 | 32 | Amgen Inc. ($74,703) |
| 2017 | $37,402 | 21 | Amgen Inc. ($24,731) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 11/14/2024 | Amgen Inc. | Nplate (Biological) | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| Category: Hematology | ||||||
| 08/15/2024 | SOBI, INC | DOPTELET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,237.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/30/2024 | Amgen Inc. | Nplate (Biological) | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| Category: Hematology | ||||||
| 07/26/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/24/2024 | Amgen Inc. | Nplate (Biological) | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| Category: Hematology | ||||||
| 02/26/2024 | SOBI, INC | DOPTELET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/23/2024 | SOBI, INC | DOPTELET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,718.94 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/23/2024 | SOBI, INC | DOPTELET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,712.96 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/19/2024 | Amgen Inc. | Nplate (Biological) | Consulting Fee | Cash or cash equivalent | $2,049.00 | General |
| Category: Hematology | ||||||
| 12/20/2023 | ARGENX US, INC. | VYVGART (Drug) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Immunology | ||||||
| 12/09/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $51.57 | General |
| 11/09/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $116.07 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 08/11/2023 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug), Coagadex | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: IVIG | ||||||
| 07/13/2023 | SOBI, INC | Doptelet (Drug) | Consulting Fee | Cash or cash equivalent | $6,937.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/23/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,136.00 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,136.00 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $1,292.39 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $1,292.39 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $398.40 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $398.40 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $199.20 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $199.20 | General |
| 06/23/2023 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $167.63 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| C-935788-057 | Rigel Pharmaceuticals, Inc. | $38,705 | 2 |
| A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia | Rigel Pharmaceuticals, Inc. | $19,966 | 4 |
| C-935788-058 | Rigel Pharmaceuticals, Inc. | $19,738 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 35 | 72 | $14,692 | $5,202 |
| 2020 | 3 | 52 | 80 | $18,009 | $4,296 |
Total Patients
87
Total Services
152
Medicare Billing
$9,497
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 59 | $12,632 | $4,632 | 36.7% |
| 86078 | Blood bank physician services for investigation of transfusion reaction with written report | Facility | 2021 | 12 | 13 | $2,060 | $570.18 | 27.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 46 | $12,243 | $2,414 | 19.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 19 | $3,379 | $1,196 | 35.4% |
| 86078 | Blood bank physician services for investigation of transfusion reaction with written report | Facility | 2020 | 15 | 15 | $2,387 | $685.61 | 28.7% |
About Dr. Terry Gernsheimer, MD
Dr. Terry Gernsheimer, MD is a Hematology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639255441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terry Gernsheimer, MD has received a total of $339,810 in payments from pharmaceutical and medical device companies, with $25,033 received in 2024. These payments were reported across 120 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($162,581).
As a Medicare-enrolled provider, Gernsheimer has provided services to 87 Medicare beneficiaries, totaling 152 services with total Medicare billing of $9,497. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 03/31/2009
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1639255441
Products in Payments
- Nplate (Biological) $92,051
- Tavalisse (Drug) $86,162
- Doptelet (Drug) $22,180
- PROMACTA (Drug) $21,799
- DOPTELET (Drug) $21,344
- Kyprolis (Biological) $19,955
- Gammaplex (Drug) $5,500
- Mulpleta (Drug) $2,488
- VYVGART (Drug) $1,400
- SOLIRIS (Drug) $80.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Seattle
Roland Walter, Md Phd, MD PHD
Hematology — Payments: $137,813
Hematology $137,813
Sandhya Panch, M.d, M.D
Hematology — Payments: $136,193
Hematology $136,193
Dr. Arthur Thompson, Md, Phd, MD, PHD
Hematology — Payments: $62,023
Hematology $62,023
Cecilia Yeung, Md, MD
Hematology — Payments: $35,242
Hematology $35,242
Dr. Kleber Yotsumoto Fertrin, Md, Phd, MD, PHD
Hematology — Payments: $27,670
Hematology $27,670
David Garcia, Md, MD
Hematology — Payments: $27,331
Hematology $27,331